A bivalent ligand (KDN-21) reveals spinal delta and kappa opioid receptors are organized as heterodimers that give rise to delta(1) and kappa(2) phenotypes. Selective targeting of delta-kappa heterodimers.

MLA

Bhushan, Rashmi G., et al. “A Bivalent Ligand (KDN-21) Reveals Spinal Delta and Kappa Opioid Receptors Are Organized as Heterodimers That Give Rise to Delta(1) and Kappa(2) Phenotypes. Selective Targeting of Delta-Kappa Heterodimers.” Journal of Medicinal Chemistry, vol. 47, no. 12, June 2004, pp. 2969–72. EBSCOhost, https://doi.org/10.1021/jm0342358.

APA

Bhushan, R. G., Sharma, S. K., Xie, Z., Daniels, D. J., & Portoghese, P. S. (2004). A bivalent ligand (KDN-21) reveals spinal delta and kappa opioid receptors are organized as heterodimers that give rise to delta(1) and kappa(2) phenotypes. Selective targeting of delta-kappa heterodimers. Journal of Medicinal Chemistry, 47(12), 2969–2972. https://doi.org/10.1021/jm0342358

Chicago

Bhushan, Rashmi G, Shiv K Sharma, Zhihua Xie, David J Daniels, and Philip S Portoghese. 2004. “A Bivalent Ligand (KDN-21) Reveals Spinal Delta and Kappa Opioid Receptors Are Organized as Heterodimers That Give Rise to Delta(1) and Kappa(2) Phenotypes. Selective Targeting of Delta-Kappa Heterodimers.” Journal of Medicinal Chemistry 47 (12): 2969–72. doi:10.1021/jm0342358.